Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
08/2003
08/07/2003CA2464138A1 Methods of preventing and treating flavivirus infection in animals
08/07/2003CA2463476A1 Novel immunogenic compositions for the prevention and treatment of meningococcal disease
08/07/2003CA2438112A1 Methods and reagents for the rapid and efficient isolation of circulating cancer cells
08/06/2003EP1333094A2 Human telomerase catalytic subunit
08/06/2003EP1332760A1 Novel epitopes for celiac disease and autoimmune diseases, methods for detecting those and novel non-antigenic food compounds
08/06/2003EP1332372A2 Net, a transcription factor of the tcf family, as regulator of angiogenic factor expression
08/06/2003EP1332369A1 Detection of infectious agents using antigen mimics
08/06/2003EP1332368A2 Methods for detecting the efficacy of anticancer treatments
08/06/2003EP1332366A1 Methods for the treatment of cellular proliferative disorders
08/06/2003EP1332209A2 Collections of repeat proteins comprising repeat modules
08/06/2003EP1332157A2 Prokineticin polypeptides, related compositions and methods
08/06/2003EP1332155A2 Immunization of dairy cattle with gapc protein against streptococcus infection
08/06/2003EP1332154A1 Novel therapeutic compositions for treating infection by lawsonia spp
08/06/2003EP1331944A1 Use of cd28-specific monoclonal antibodies for stimulating blood cells that lack cd28
08/06/2003EP1331943A2 Nucleic acid molecules and polypeptides for immune modulation
08/06/2003EP1331942A2 Immunogen comprising ligand bound hiv envelope protein
08/06/2003EP1331940A1 Use of the long pentraxin ptx3 for the treatment of diseases caused by an altered activation of the growth factor fgf-2
08/06/2003EP1162945B1 Particle based vaccine composition
08/06/2003EP1140152B1 Method to produce inactivated w/o emulsion adjuvated vaccines
08/06/2003EP1098664B1 Conjugates for treating inflammatory disorders and associated tissue damage
08/06/2003EP0702563B1 Compositions and methods for treating cancer and hyperproliferative disorders
08/06/2003EP0687182B1 Peptides for inducing cytotoxic t lymphocyte responses to hepatitis b virus
08/06/2003CN1434923A Conformational and topolodical protein regulation
08/06/2003CN1434865A Regulation effect of conjugated frame transport protein ABC1
08/06/2003CN1434864A Method of enhancing immune responses to herpes simplex virus vaccine
08/06/2003CN1434862A Improvement of nucleic acid vaccination
08/06/2003CN1434832A DNA for encoding the RGI polypeptide
08/06/2003CN1434831A Improvments in or relating to immune responses to HIV
08/06/2003CN1434795A Acyl pseudodipeptides which carry a functionalised auxiliary arm
08/06/2003CN1434723A Immunostimulatory oligodeoxynucleotides
08/06/2003CN1434722A Use of il-18 inhibitors for the treatment and/or prevention of atherosclerosis
08/06/2003CN1434718A Activation and inhibition of immune system
08/06/2003CN1434056A Method for producing recombination human hepatitis B virus core antigen
08/06/2003CN1433812A Duplication double localization type intracellular vaccine
08/06/2003CN1117155C Novel compounds
08/06/2003CN1117150C EB virus DNA sequences encoding diagnostically releavant virus capid antigen expression clones derived through polymerase chain reaction and use of this recombinant antigen in diagnostic
08/06/2003CN1117149C Compounds and methods for immunotherapy and diagnosis of tuberculosis
08/06/2003CN1117148C Vaccineforinfections agents, compositions for treating and preventing HIV infections
08/06/2003CN1116898C Oral immune globulin preparation and its preparing process
08/06/2003CN1116869C Use of THF-alpha-antagonist for treating neurogenic skin redness
08/05/2003US6603998 Delivery of macromolecules into cells
08/05/2003US6602986 Antibody comprising a heavy and light chain, each comprising three nonnaturally occuring chain determining regions; antibody specifically binds to human antigen
08/05/2003US6602853 Antigenic peptides reacting with anti-ovary antibodies
08/05/2003US6602709 Methods for use of apoptotic cells to deliver antigen to dendritic cells for induction or tolerization of T cells
08/05/2003US6602707 Mammalian cell surface DNA receptor-encoding nucleic acid
08/05/2003US6602705 Expression of HIV polypeptides and production of virus-like particles
08/05/2003US6602697 Process for purifying human papillomavirus virus-like particles
08/05/2003US6602688 Transforming a thioredoxin reductase-deficient Escherichia strain with a nucleotide molecule encoding antibody; culturing; enzyme cleaves nontoxic prodrug to give the toxic drug; antitumor agent
08/05/2003US6602687 Culturing bacterial cells transformed with a bacterial expression vector comprising given DNA sequence; may be used in the treatment of neurological disorders, such as Alzheimer's disease, and treating spinal cord damage
08/05/2003US6602684 Culturing a host cell to express a nucleic acid encoding beta (1,4)-N- acetylglucosaminyltransferase III under conditions for production of a polypeptide; can use to provide proteins with improved therapeutic properties
08/05/2003US6602667 Of given sequence; useful for diagnosis, prognosis, treatment of inflammatory disorders; screening to identify ligands which bind the polynucleotides
08/05/2003US6602510 Eight isolated epitopes YLSGANLNV (SEQ ID NO:1), IMIGVLVGV (SEQ ID NO:2), KLBPVQLWV (SEQ ID NO:3), SMPPPGTRV (SEQ ID NO:4), KVAELVHFL (SEQ ID NO:5), YLQLVFGIEV (SEQ ID NO:6), RLLQETELV (SEQ ID NO:7), and, VVLGVVFGI (SEQ ID NO:8).
08/05/2003US6602509 Compound and method for the prevention and/or the treatment of allergy
08/05/2003US6602508 Method of immunization using a Group B Streptococcus type II and type III polysaccharide conjugate vaccine
08/05/2003US6602507 Polypeptides from the conserved region of the M protein elicit a protective immune response against streptococcal infection
08/05/2003US6602506 Immunogenic composition; bactericidal
08/05/2003US6602505 Polynucleotide comprising caprine arthritis encephalitis virus (CAEV) viral genome renders nonpathogenic to a primate a resulting retroviral particle produced via gene expression, generating immune response against HIV-1
08/05/2003US6602504 Useful in prophylaxis, therapy, and diagnosis of infections in canines
08/05/2003US6602503 Complementarity determining regions (CDRs); asthma and inflammatory bowel disease; integrins; antigen binding regions derived from the heavy and/ or light chain variable regions
08/05/2003US6602502 Improved immunoassays of psychotomimetic drugs, narcotic drugs, tetrahydrocannabinols; use of the haptenic properties of psychoactive material; blood test N,N-Dimethyltryptamine and 5-Methoxy-N,N- Dimethyltryptamine
08/05/2003US6602501 C-type lectin transmembrane antigen expressed in human prostate cancer and uses thereof
08/05/2003CA1341436C Synthetic antigens for the detection of aids-related disease caused by lav-2
08/03/2003WO2003064618A2 Immune response replication in cloned animals
08/03/2003CA2474901A1 Immune response replication in cloned animals
07/2003
07/31/2003WO2003062424A1 Nucleic acid sequence comprising the rna packaging signal of a group 1 coronavirus and the applications thereof
07/31/2003WO2003062413A1 Synthetic peptides and uses thereof for the prevention and therapy of cancer invasion and metastasis
07/31/2003WO2003062407A1 INFECTIOUS cDNA CLONES OF PORCINE REPRODUCTIVE AND RESPIRATORY SYNDROME VIRUS AND EXPRESSION VECTORS THEREOF
07/31/2003WO2003062401A2 Compositions and methods for the detection, diagnosis and therapy of hematological malignancies
07/31/2003WO2003062390A2 Compositions and methods for the modulation of sphingolipid metabolism and/or signaling
07/31/2003WO2003062377A2 COMPLETE GENOME SEQUENCE OF SIVcpzTAN1
07/31/2003WO2003062375A2 Stabilizing polypeptides which have been exposed to urea
07/31/2003WO2003062374A2 Synthetic genes for malarial proteins and methods of use
07/31/2003WO2003062370A2 Multimeric proteins and methods of making and using same
07/31/2003WO2003062278A1 MONOCLONAL ANTIBODIES AGAINST EXTRACELLULAR LOOPS OF C5aR
07/31/2003WO2003062274A1 Novel proteins and dnas thereof
07/31/2003WO2003062271A1 Peptides and nucleic acids of the cathelicidin family, derived from fish, and uses thereof
07/31/2003WO2003062262A2 Modulation of heat-shock-protein-based immunotherapies
07/31/2003WO2003061695A1 Methods of regulating cytokine receptor signaling
07/31/2003WO2003061692A2 Hepatitis b virus surface antigen as a mucosal immunostimulator and the resulting formulations
07/31/2003WO2003061659A1 Treating stress response with chemokine receptor ccr5 modulators
07/31/2003WO2003061636A2 Dna dosage forms
07/31/2003WO2003061629A2 Dna dosage forms
07/31/2003WO2003061595A2 Antibodies against and compositions containing new amphetamine derivatives
07/31/2003WO2003061590A2 Peptide constructs for treating disease
07/31/2003WO2003061589A2 Methods for treating diseases or conditions with peptide constructs
07/31/2003WO2003061580A2 Alteration of rab38 function to modulate mammalian pigmentation
07/31/2003WO2003061578A2 Compositions for treatment or prevention of bioterrorism
07/31/2003WO2003061577A2 Polyalkylene glycol with moiety for conjugating biologically active compound
07/31/2003WO2003061573A2 Methods and compositions for treating urological disorders using 1435, 559, 34021, 44099, 25278, 641, 260, 55089, 21407, 42032, 46656, 62553, 302, 323, 12303, 985, 13237, 13601, 18926, 318, 2058 or 6351 mo
07/31/2003WO2003061571A2 Combination il-2/anti-herz antibody therapy for cancers characterized by overexpression of the her2 receptor protein
07/31/2003WO2003061560A2 Replication competent dual-ad vectors for vaccine and immunotherapy applications
07/31/2003WO2003061558A2 Glycoconjugate vaccines for use in immune-compromised populations
07/31/2003WO2003061555A2 West nile vaccine
07/31/2003WO2003061520A2 Methods of modulating angiogenesis
07/31/2003WO2003061519A2 Methods and compositions for preserving the viability of photoreceptor cells
07/31/2003WO2003045978A3 Antagonist anti-cd40 monoclonal antibody therapy for multiple sclerosis treatment
07/31/2003WO2003037253A3 Methods for the treatment and diagnosis of tumorigenic and angiogenic disorders using 32616
07/31/2003WO2003029484A3 Antimicrobial methods and materials
07/31/2003WO2003024388A3 Methods and compositions for treating and preventing skin disorders using binding agents specific for psma
07/31/2003WO2003016333A3 Virus coat protein/receptor chimeras and methods of use
1 ... 1226 1227 1228 1229 1230 1231 1232 1233 1234 1235 1236 1237 1238 1239 1240 1241 1242 1243 1244 1245 1246 ... 1823